Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · CHIEF EXECUTIVE OFFICER | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 806,111 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Tax withholding · Disposed 5,361 · Balance 806,111 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1 |
Reported balance
Holding disclosure · report date 2026-09-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1 F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2023 Filed Jun 7, 2023 22:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,514 | $40.65 | $305,444.10 |
DisclosureSEC source: 0001628280-23-021337 · wf-form4_168617656492851.xml · nonDerivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 224,410 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.10 to $41.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 22:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 16,000 | $3.95 | $63,200.00 |
DisclosureSEC source: 0001628280-23-021337 · wf-form4_168617656492851.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-021337 · wf-form4_168617656492851.xml · derivative · entry 13 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 827,556 Underlying: Common Stock · 16,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These shares are fully vested and exercisable. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 74 | $40.74 | $3,014.76 |
DisclosureSEC source: 0001628280-23-021337 · wf-form4_168617656492851.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 24,597 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.71 to $40.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,019 | $40.23 | $121,454.37 |
DisclosureSEC source: 0001628280-23-021337 · wf-form4_168617656492851.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 24,671 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.68 to $40.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 907 | $39.19 | $35,545.33 |
DisclosureSEC source: 0001628280-23-021337 · wf-form4_168617656492851.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 27,690 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.64 to $39.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 296 | $40.74 | $12,059.04 |
DisclosureSEC source: 0001628280-23-021337 · wf-form4_168617656492851.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.71 to $40.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 12,075 | $40.23 | $485,777.25 |
DisclosureSEC source: 0001628280-23-021337 · wf-form4_168617656492851.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,220 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.68 to $40.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,629 | $39.19 | $142,220.51 |
DisclosureSEC source: 0001628280-23-021337 · wf-form4_168617656492851.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,295 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.64 to $39.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 22:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 16,000 | $3.95 | $63,200.00 |
DisclosureSEC source: 0001628280-23-021337 · wf-form4_168617656492851.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 21:08 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-020904 · wf-form4_168599929073582.xml · derivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 843,556 Underlying: Common Stock · 16,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These shares are fully vested and exercisable. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 21:08 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,000 | $38.67 | $154,680.00 |
DisclosureSEC source: 0001628280-23-020904 · wf-form4_168599929073582.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 28,597 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.09 to $39.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 21:08 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 16,000 | $38.67 | $618,720.00 |
DisclosureSEC source: 0001628280-23-020904 · wf-form4_168599929073582.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.09 to $39.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 21:08 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 16,000 | $3.95 | $63,200.00 |
DisclosureSEC source: 0001628280-23-020904 · wf-form4_168599929073582.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:08 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-020904 · wf-form4_168599929073582.xml · derivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 859,556 Underlying: Common Stock · 16,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These shares are fully vested and exercisable. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:08 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,301 | $37.85 | $49,242.85 |
DisclosureSEC source: 0001628280-23-020904 · wf-form4_168599929073582.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 32,597 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.78 to $37.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:08 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,699 | $37.41 | $100,969.59 |
DisclosureSEC source: 0001628280-23-020904 · wf-form4_168599929073582.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 33,898 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.79 to $37.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:08 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,205 | $37.85 | $197,009.25 |
DisclosureSEC source: 0001628280-23-020904 · wf-form4_168599929073582.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.78 to $37.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:08 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 10,795 | $37.41 | $403,840.95 |
DisclosureSEC source: 0001628280-23-020904 · wf-form4_168599929073582.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 221,129 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.79 to $37.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:08 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 16,000 | $3.95 | $63,200.00 |
DisclosureSEC source: 0001628280-23-020904 · wf-form4_168599929073582.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2023 Filed May 18, 2023 23:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,608 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018932 · wf-form4_168445205200361.xml · derivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 875,556 Underlying: Common Stock · 4,608 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These shares will become fully vested and exercisable on May 23, 2023. Read SEC document |
| May 16, 2023 Filed May 18, 2023 23:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,153 | $35.94 | $41,438.82 |
DisclosureSEC source: 0001628280-23-018932 · wf-form4_168445205200361.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 36,597 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.35 to $36.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 16, 2023 Filed May 18, 2023 23:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,608 | $35.94 | $165,611.52 |
DisclosureSEC source: 0001628280-23-018932 · wf-form4_168445205200361.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.35 to $36.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2023 Filed May 18, 2023 23:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 4,608 | $3.95 | $18,201.60 |
DisclosureSEC source: 0001628280-23-018932 · wf-form4_168445205200361.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 16, 2023 21:29 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018491 · wf-form4_168427253200558.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 880,164 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These shares will become fully vested and exercisable on May 23, 2023. Read SEC document |
| May 15, 2023 Filed May 16, 2023 21:29 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,000 | $36.24 | $289,920.00 |
DisclosureSEC source: 0001628280-23-018491 · wf-form4_168427253200558.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 31,655 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.92 to $36.81, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 15, 2023 Filed May 16, 2023 21:29 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 32,000 | $36.24 | $1,159,680.00 |
DisclosureSEC source: 0001628280-23-018491 · wf-form4_168427253200558.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.92 to $36.81, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2023 Filed May 16, 2023 21:29 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-018491 · wf-form4_168427253200558.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2023 Filed May 16, 2023 21:29 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018491 · wf-form4_168427253200558.xml · derivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 912,164 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These shares will become fully vested and exercisable on May 23, 2023. Read SEC document |
| May 12, 2023 Filed May 16, 2023 21:29 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,000 | $36.30 | $290,400.00 |
DisclosureSEC source: 0001628280-23-018491 · wf-form4_168427253200558.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 39,655 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.85 to $36.68, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 12, 2023 Filed May 16, 2023 21:29 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 32,000 | $36.30 | $1,161,600.00 |
DisclosureSEC source: 0001628280-23-018491 · wf-form4_168427253200558.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.85 to $36.68, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 12, 2023 Filed May 16, 2023 21:29 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-018491 · wf-form4_168427253200558.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · derivative · entry 12 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 944,164 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These shares will become fully vested and exercisable on May 23, 2023. Read SEC document |
| May 11, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 294 | $37.19 | $10,933.86 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · nonDerivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 47,655 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.03 to $37.32, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 11, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,706 | $36.46 | $280,960.76 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · nonDerivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 47,949 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.035 to $37.02, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 11, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,177 | $37.19 | $43,772.63 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.03 to $37.32, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 30,823 | $36.46 | $1,123,806.58 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,101 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.035 to $37.02, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 247,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · derivative · entry 11 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 976,164 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These shares will become fully vested and exercisable on May 23, 2023. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 462 | $38.48 | $17,777.76 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 55,655 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.30 to $38.66, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,538 | $37.69 | $284,107.22 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 56,117 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.29 to $38.27, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,849 | $38.48 | $71,149.52 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.30 to $38.66, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 30,151 | $37.69 | $1,136,391.19 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,773 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.29 to $38.27, inclusive. The Reporting Person undertakes to provide tothe Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:21 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-23-017906 · wf-form4_168392286804233.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 247,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · derivative · entry 12 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,008,164 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These shares will become fully vested and exercisable on May 23, 2023. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,568 | $38.24 | $59,960.32 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · nonDerivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 63,655 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $38.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,095 | $37.61 | $229,232.95 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · nonDerivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 65,223 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.05 to $38.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 337 | $36.76 | $12,388.12 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 77,413 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $37.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,270 | $38.24 | $239,764.80 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,924 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $38.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:24 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 24,382 | $37.61 | $917,007.02 |
DisclosureSEC source: 0001628280-23-017250 · wf-form4_168375023131504.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,194 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.05 to $38.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.